Cargando…
Clinical effectiveness of tigecycline in combination therapy against nosocomial pneumonia caused by CR-GNB in intensive care units: a retrospective multi-centre observational study
BACKGROUND: Tigecycline has in vitro bacteriostatic activity against a broad spectrum of bacteria, including carbapenem-resistant Gram-negative bacteria (CR-GNB). However, the role of tigecycline in treatment of nosocomial pneumonia caused by CR-GNB remains controversial and clinical evidences are l...
Autores principales: | Yang, Kuang-Yao, Peng, Chung-Kan, Sheu, Chau-Chyun, Lin, Yu-Chao, Chan, Ming-Cheng, Wang, Sheng-Huei, Chen, Chia-Min, Chen, Chih-Yu, Zheng, Zhe-Rong, Feng, Jia-Yih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808925/ https://www.ncbi.nlm.nih.gov/pubmed/36597165 http://dx.doi.org/10.1186/s40560-022-00647-y |
Ejemplares similares
-
Efficacies of Colistin–Carbapenem versus Colistin–Tigecycline in Critically Ill Patients with CR-GNB-Associated Pneumonia: A Multicenter Observational Study
por: Wang, Sheng-Huei, et al.
Publicado: (2021) -
Role of nebulized colistin as a substitutive strategy against nosocomial pneumonia caused by CR-GNB in intensive care units: a retrospective cohort study
por: Feng, Jia-Yih, et al.
Publicado: (2023) -
Clinical outcome of nosocomial pneumonia caused by Carbapenem-resistant gram-negative bacteria in critically ill patients: a multicenter retrospective observational study
por: Chen, Chih-Yu, et al.
Publicado: (2022) -
The prevalence, presentation and outcome of colistin susceptible-only Acinetobacter Baumannii-associated pneumonia in intensive care unit: a multicenter observational study
por: Wang, Sheng-Huei, et al.
Publicado: (2023) -
The necessity of a loading dose when prescribing intravenous colistin in critically ill patients with CRGNB-associated pneumonia: a multi-center observational study
por: Wang, Sheng-Huei, et al.
Publicado: (2022)